uniQure Announces Pricing of its Public Offering
QURE Stock | USD 15.74 0.05 0.32% |
About 69 percent of all Uniqure NV's shareholders are curious in acquiring. The analysis of the overall investor sentiment regarding Uniqure NV suggests that quite a large number of traders are confidant. The current market sentiment, together with Uniqure NV's historical and current headlines, can help investors time the market. In addition, many technical investors use Uniqure NV stock news signals to limit their universe of possible portfolio assets.
Uniqure |
LEXINGTON, Mass. and AMSTERDAM, Jan. 08, 2025 -- uniQure N.V. , a leading gene therapy company advancing transformative therapies for
Read at gurufocus.com
Uniqure NV Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Uniqure NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Uniqure NV Maximum Pain Price Across April 17th 2025 Option Contracts
Uniqure NV's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Uniqure NV close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Uniqure NV's options.
Uniqure NV Fundamental Analysis
We analyze Uniqure NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Uniqure NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Uniqure NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Uniqure NV is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Uniqure NV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Uniqure NV stock to make a market-neutral strategy. Peer analysis of Uniqure NV could also be used in its relative valuation, which is a method of valuing Uniqure NV by comparing valuation metrics with similar companies.
Peers
Uniqure NV Related Equities
TERN | Terns Pharmaceuticals | 7.18 | ||||
LRMR | Larimar Therapeutics | 5.12 | ||||
AMLX | Amylyx Pharmaceuticals | 4.84 | ||||
ABOS | Acumen Pharmaceuticals | 3.85 | ||||
REPL | Replimune | 2.35 | ||||
RGNX | Regenxbio | 2.15 | ||||
RNA | Avidity Biosciences | 1.29 | ||||
GPCR | Structure Therapeutics | 0.76 | ||||
INZY | Inozyme Pharma | 0.68 | ||||
RCKT | Rocket Pharmaceuticals | 0.47 | ||||
RYTM | Rhythm Pharmaceuticals | 0.35 | ||||
XFOR | X4 Pharmaceuticals | 0.03 | ||||
SNDX | Syndax Pharmaceuticals | 0.56 | ||||
KNSA | Kiniksa Pharmaceuticals | 1.41 | ||||
STRO | Sutro Biopharma | 1.54 | ||||
MRUS | Merus BV | 1.64 | ||||
MGTX | MeiraGTx Holdings | 2.64 | ||||
PTGX | Protagonist Therapeutics | 3.02 | ||||
DAWN | Day One | 3.69 | ||||
PCVX | Vaxcyte | 3.70 | ||||
SLDB | Solid Biosciences | 4.22 | ||||
PHAT | Phathom Pharmaceuticals | 5.52 |
Complementary Tools for Uniqure Stock analysis
When running Uniqure NV's price analysis, check to measure Uniqure NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Uniqure NV is operating at the current time. Most of Uniqure NV's value examination focuses on studying past and present price action to predict the probability of Uniqure NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Uniqure NV's price. Additionally, you may evaluate how the addition of Uniqure NV to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |